To understand why this peptide does not affect hunger, cortisol, or eating behavior, it is essential to examine where and how it acts within the bodys metabolic pathways
TB-500 safety data is less extensive but similarly suggests good tolerability in preclinical models
References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
Sharper thinking, improved mood, and better metabolic function
TB-500 : Preclinical cardiac and muscle repair studies have reported good tolerability of TB-500, with no signs of organ toxicity or inflammatory overstimulation